Publications of Astrid Sydow
All genres
Journal Article (7)
2023
Journal Article
24 (11), 9260 (2023)
Reversal of Tau-dependent cognitive decay by blocking adenosine A1 receptors: Comparison of transgenic mouse models with different levels of tauopathy. International Journal of Molecular Sciences 2019
Journal Article
14, 13 (2019)
Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model. Molecular Neurodegeneration 2016
Journal Article
17 (4), pp. 552 - 569 (2016)
The Tau/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity. EMBO Reports
Journal Article
113 (41), pp. 11597 - 11602 (2016)
Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau δK280. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
4, 17 (2016)
Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD. Acta Neuropathologica Communications 2013
Journal Article
280 (18), pp. 4371 - 4381 (2013)
Regulatable transgenic mouse models of Alzheimer disease: Onset, reversibility and spreading of Tau pathology. FEBS Journal 2012
Journal Article
123 (6), pp. 787 - 805 (2012)
Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. Acta Neuropathologica